1. Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

   • Katie Hoyles
   • Jagdish C. Sharma

   Review 03 February 2013 Pages: 2951 - 2958

2. Multiple sclerosis in the Arabian Gulf countries: a consensus statement

   • Saeed Bohlega
   • Jihad Inshasi
   • Peter Rieckmann

   Review Open access 17 March 2013 Pages: 2959 - 2963

3. Ambulatory activity in incident Parkinson’s: more than meets the eye?

   • Sue Lord
   • Alan Godfrey
   • Lynn Rochester

   Original Communication 31 July 2013 Pages: 2964 - 2972

   

4. Erratum to: Ambulatory activity in incident Parkinson’s: more than meets the eye?

   • Sue Lord
   • Alan Godfrey
   • Lynn Rochester

   Erratum 29 October 2013 Pages: 2973 - 2973

   

5. Motor fluctuations and Helicobacter pylori in Parkinson’s disease

   • Karl-Erik Rahne
   • Carl Tagesson
   • Dag Nyholm

   Original Communication 04 September 2013 Pages: 2974 - 2980

6. Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

   • Stefan Braune
   • M. Lang
   • NTC Study Group

   Original Communication Open access 06 September 2013 Pages: 2981 - 2985

   

7. Cortical hemichorea–hemiballism

   • Kyoung Jin Hwang
   • Il Ki Hong
   • Deog Yoon Kim

   Original Communication 06 September 2013 Pages: 2986 - 2992

   

8. Endurance training in MS: short-term immune responses and their relation to cardiorespiratory fitness, health-related quality of life, and fatigue

   • J. Bansi
   • W. Bloch
   • J. Kesselring

   Original Communication 14 September 2013 Pages: 2993 - 3001

   

9. Prominent psychiatric symptoms in patients with Parkinson’s disease and concomitant argyrophilic grain disease

   • O. Grau-Rivera
   • E. Gelpi
   • M. J. Martí

   Original Communication 18 September 2013 Pages: 3002 - 3009

   

10. Novel CACNA1A mutation(s) associated with slow saccade velocities

    • Stefan Kipfer
    • Simon Jung
    • René M. Müri

    Original Communication 18 September 2013 Pages: 3010 - 3014

    

11. The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach

    • Alain Créange
    • Arnold Careyron
    • The French CIDP study group

    Original Communication 20 September 2013 Pages: 3015 - 3022

    

12. Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients

    • Fumi Takeuchi
    • Naohiro Yonemoto
    • Shin’ichi Takeda

    Original Communication Open access 22 September 2013 Pages: 3023 - 3029

    

13. Intravenous amantadine on freezing of gait in Parkinson’s disease: a randomized controlled trial

    • Jee Young Lee
    • Sohee Oh
    • Jin Whan Cho

    Original Communication 22 September 2013 Pages: 3030 - 3038

    

14. Vestibular rehabilitation outcomes in patients with and without vestibular migraine

    • Jessica Vitkovic
    • Arimbi Winoto
    • Mark Paine

    Original Communication 24 September 2013 Pages: 3039 - 3048

    

15. Outcome of patients with atrial fibrillation after intravenous thrombolysis for cerebral ischaemia

    • Visnja Padjen
    • Marie Bodenant
    • Didier Leys

    Original Communication 26 September 2013 Pages: 3049 - 3054

    

16. Glucose metabolism in nine patients with probable sporadic Creutzfeldt–Jakob disease: FDG-PET study using SPM and individual patient analysis

    • Dimitri Renard
    • Rik Vandenberghe
    • Vincent Boudousq

    Original Communication 26 September 2013 Pages: 3055 - 3064

    

17. Optic neuropathy in Behçet’s syndrome

    • Desmond P. Kidd

    Original Communication 26 September 2013 Pages: 3065 - 3070

18. Results of the PERFORM magnetic resonance imaging study

    • H. Chabriat
    • P. Maeder
    • M. G. Hennerici

    Original Communication 29 September 2013 Pages: 3071 - 3076

19. Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson’s disease

    • Uwe Walter
    • Sabine Kleinschmidt
    • Knut Busse

    Original Communication 02 October 2013 Pages: 3077 - 3085

    

20. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies

    • Yasushi Hosoi
    • Makiko Suzuki-Sakao
    • Satoshi Kono

    Original Communication 05 October 2013 Pages: 3086 - 3092

    

21. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy

    • Maike F. Dohrn
    • Christoph Röcken
    • Kristl G. Claeys

    Original Communication 08 October 2013 Pages: 3093 - 3108

    

22. Physiological variation of segmented OCT retinal layer thicknesses is short-lasting

    • Lisanne Balk
    • Markus Mayer
    • Axel Petzold

    Original Communication 08 October 2013 Pages: 3109 - 3114

    

23. Ultrasound of inherited vs. acquired demyelinating polyneuropathies

    • Craig M. Zaidman
    • Matthew B. Harms
    • Alan Pestronk

    Original Communication 08 October 2013 Pages: 3115 - 3121

    

24. Usefulness of intravenous lacosamide in status epilepticus

    • Estevo Santamarina
    • Manuel Toledo
    • Xavier Salas Puig

    Original Communication 12 October 2013 Pages: 3122 - 3128

25. Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson’s disease and controls

    • Megan K. Herbert
    • H. Bea Kuiperij
    • Marcel M. Verbeek

    Original Communication 12 October 2013 Pages: 3129 - 3133

26. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2

    • Roberto Fancellu
    • Dominga Paridi
    • Floriano Girotti

    Original Communication 12 October 2013 Pages: 3134 - 3143

27. Variations of mitochondrial DNA polymerase γ in patients with Parkinson’s disease

    • S. Ylönen
    • P. Ylikotila
    • K. Majamaa

    Original Communication 12 October 2013 Pages: 3144 - 3149

28. Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder

    • Youming long
    • Yihua He
    • Cong Gao

    Original Communication 12 October 2013 Pages: 3150 - 3157

    

29. Selective hyposmia in Parkinson’s disease?

    • Antje Hähner
    • Wakunyambo Maboshe
    • Thomas Hummel

    Letter to the Editors 25 October 2013 Pages: 3158 - 3160

    

30. Juvenile parkinsonism as an initial manifestation of gliomatosis cerebri

    • Wooyoung Jang
    • Seung Hyun Ha
    • Hee-Jin Kim

    Letter to the Editors 25 October 2013 Pages: 3161 - 3163

    

31. Altered GABAergic system in the living brain of a patient with spinocerebellar ataxia type 8

    • Tatsuhiro Terada
    • Satoshi Kono
    • Yasuomi Ouchi

    Letter to the Editors 27 October 2013 Pages: 3164 - 3166

    

32. Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis

    • Ryo Kuroda
    • Junko Suzuki
    • Masahiro Kobari

    Letter to the Editors Open access 01 November 2013 Pages: 3167 - 3170

    

33. Sporadic late-onset nemaline myopathy in a patient with systemic lupus erythematosus

    • Dalia Dimitri
    • Odile Dubourg

    Letter to the Editors 01 November 2013 Pages: 3171 - 3173

    

34. The impact of guidelines on the quality of MRI diagnostics in adult patients referred to a tertiary Epilepsy Centre

    • Bernhard J. Steinhoff
    • Matthias Bacher
    • Anke M. Staack

    Letter to the Editors 08 November 2013 Pages: 3174 - 3175

35. MR neurography of acute and regenerated brachial plexus pressure palsy

    • Lars Behrens
    • Philipp Bäumer
    • Mirko Pham

    Letter to the Editors 08 November 2013 Pages: 3176 - 3177

    

36. Ischemic stroke as clinical onset of POEMS syndrome

    • P. Dacci
    • F. Lessi
    • G. Lauria

    Letter to the Editors 13 November 2013 Pages: 3178 - 3181

    

37. Enhanced reticulospinal output in patients with (REEP1) hereditary spastic paraplegia type 31

    • K. M. Fisher
    • P. F. Chinnery
    • M. R. Baker

    Letter to the Editors Open access 13 November 2013 Pages: 3182 - 3184

    

38. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis

    • Marco Zoccarato
    • Maria Valeria Saddi
    • Luigi Zuliani

    Letter to the Editors 20 November 2013 Pages: 3185 - 3187

    

39. Progress in peripheral nerve disease research in the last two years

    • Matthew Evans
    • Hadi Manji

    Medical Progress in the Journal of Neurology 25 October 2013 Pages: 3188 - 3192

40. Possible treatment targets in Alzheimer’s disease

    • A. Pryce Roberts
    • N. P. Robertson

    Journal club 24 November 2013 Pages: 3193 - 3196

41. Norman Geschwind (1926–1984)

    • Stefano Sandrone

    Pioneers in Neurology 03 March 2013 Pages: 3197 - 3198

    

42. Erratum to: R208H-129VV haplotype in the prion protein gene: phenotype and neuroimaging of a patient with genetic Creutzfeldt-Jakob disease

    • Maria Gabriella Vita
    • Simona Gaudino
    • Carlo Masullo

    Erratum 29 October 2013 Pages: 3199 - 3199